CA Stock MarketDetailed Quotes

IPCI.H IntelliPharmaCeutics International Inc

Watchlist
  • 0.080
  • 0.0000.00%
15min DelayMarket Closed Mar 5 10:01 ET
2.65MMarket Cap-655P/E (TTM)

IntelliPharmaCeutics International Inc Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Aug 31, 2023
(Q2)May 31, 2023
(Q1)Feb 28, 2023
(FY)Nov 30, 2022
(Q4)Nov 30, 2022
(Q3)Aug 31, 2022
(Q2)May 31, 2022
(Q1)Feb 28, 2022
(FY)Nov 30, 2021
(Q4)Nov 30, 2021
Total revenue
260.38%68.72K
480.2K
291.25%326.34K
65.73K
29.68K
19.07K
0
83.41K
0
0
Operating revenue
260.38%68.72K
--480.2K
391.24%326.34K
--48.75K
--12.7K
--19.07K
--0
--66.43K
--0
--0
Cost of revenue
17.43K
0
Gross profit
168.99%51.29K
19.07K
Operating expense
364.35%1.79M
-59.14%511.56K
-26.69%627.74K
-30.12%2.92M
-36.52%887.09K
-64.45%385.25K
25.15%1.25M
9.10%856.33K
-31.36%4.17M
-20.68%1.4M
Selling and administrative expenses
166.21%193.53K
-61.60%93.5K
-46.78%138.84K
-55.10%561.05K
6.01%348.99K
-199.01%-292.3K
-46.27%243.5K
51.62%260.86K
-41.81%1.25M
-41.51%329.19K
Research and development costs
148.34%1.55M
-60.55%377.51K
-17.62%448.17K
-19.26%2.15M
-51.49%486.48K
-13.43%626.07K
98.65%956.85K
-0.64%543.99K
-24.31%2.66M
-8.07%1M
Depreciation amortization depletion
-21.08%40.63K
-21.24%40.55K
-20.86%40.74K
-21.21%206.06K
-21.04%51.62K
-21.26%51.48K
-21.26%51.48K
-21.27%51.48K
-37.04%261.53K
-39.46%65.38K
-Depreciation and amortization
-21.08%40.63K
-21.24%40.55K
-20.86%40.74K
-21.21%206.06K
-21.04%51.62K
-21.26%51.48K
-21.26%51.48K
-21.27%51.48K
-37.04%261.53K
-39.46%65.38K
Operating profit
-374.52%-1.74M
97.50%-31.36K
61.00%-301.4K
31.69%-2.85M
67.11%-459.58K
66.21%-366.18K
-38.04%-1.25M
1.53%-772.92K
10.80%-4.17M
4.44%-1.4M
Net non-operating interest income (expenses)
-26.13%-66.89K
29.37%-51.89K
49.52%-50.76K
46.91%-291.62K
64.49%-64.56K
75.04%-53.03K
7.52%-73.47K
-33.02%-100.56K
43.35%-549.3K
-120.87%-181.81K
Non-operating interest income
--0
----
----
----
----
--0
----
----
----
----
Non-operating interest expense
26.13%66.89K
-29.37%51.89K
-49.52%50.76K
-46.91%291.62K
-64.49%64.56K
-75.04%53.03K
-7.52%73.47K
33.02%100.56K
-43.35%549.3K
120.87%181.81K
Other net income (expenses)
-128.39%-34.97K
-93.99%29.12K
52.26%-3.58K
147.50%255.07K
29.68%-345.25K
285.31%123.17K
3,587.64%484.64K
88.30%-7.49K
-123.45%-536.97K
-1,002.27%-490.99K
Gain on sale of security
-128.39%-34.97K
289.63%29.12K
52.26%-3.58K
1,037.61%210.63K
369.08%110.31K
285.31%123.17K
-10.51%-15.36K
88.30%-7.49K
86.67%-22.47K
198.46%23.52K
Special income (charges)
--0
--0
----
108.64%44.44K
11.46%-455.57K
--0
--500K
----
-1,136.69%-514.5K
-2,390.45%-514.5K
-Less:Impairment of capital assets
----
----
----
--0
----
----
----
----
--514.5K
----
-Gain on sale of property,plant,equipment
--0
--0
----
--44.44K
---455.57K
--0
--500K
----
--0
--0
Income before tax
-521.36%-1.84M
93.56%-54.12K
59.62%-355.74K
45.11%-2.89M
58.01%-869.39K
76.58%-296.04K
15.95%-840.65K
4.72%-880.97K
-56.62%-5.26M
-30.27%-2.07M
Income tax
104.67%5.34K
-447.78%-114.19K
Earnings from equity interest net of tax
Net income
-521.36%-1.84M
93.56%-54.12K
59.62%-355.74K
43.78%-2.89M
55.28%-874.73K
76.58%-296.04K
15.95%-840.65K
4.72%-880.97K
-51.73%-5.15M
-20.59%-1.96M
Net income continuous operations
-521.36%-1.84M
93.56%-54.12K
59.62%-355.74K
43.78%-2.89M
55.28%-874.73K
76.58%-296.04K
15.95%-840.65K
4.72%-880.97K
-51.73%-5.15M
-20.59%-1.96M
Noncontrolling interests
Net income attributable to the company
-538.16%-1.89M
93.56%-54.12K
59.62%-355.74K
43.78%-2.89M
55.28%-874.73K
76.58%-296.04K
15.95%-840.65K
4.72%-880.97K
-51.73%-5.15M
-20.59%-1.96M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
-538.16%-1.89M
93.56%-54.12K
59.62%-355.74K
43.78%-2.89M
55.28%-874.73K
76.58%-296.04K
15.95%-840.65K
4.72%-880.97K
-51.73%-5.15M
-20.59%-1.96M
Diluted earnings per share
-500.00%-0.06
93.33%-0.002
66.67%-0.01
47.06%-0.09
66.67%-0.02
75.00%-0.01
25.00%-0.03
25.00%-0.03
-21.43%-0.17
0.00%-0.06
Basic earnings per share
-500.00%-0.06
93.33%-0.002
66.67%-0.01
47.06%-0.09
66.67%-0.02
75.00%-0.01
25.00%-0.03
25.00%-0.03
-21.43%-0.17
0.00%-0.06
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Aug 31, 2023(Q2)May 31, 2023(Q1)Feb 28, 2023(FY)Nov 30, 2022(Q4)Nov 30, 2022(Q3)Aug 31, 2022(Q2)May 31, 2022(Q1)Feb 28, 2022(FY)Nov 30, 2021(Q4)Nov 30, 2021
Total revenue 260.38%68.72K480.2K291.25%326.34K65.73K29.68K19.07K083.41K00
Operating revenue 260.38%68.72K--480.2K391.24%326.34K--48.75K--12.7K--19.07K--0--66.43K--0--0
Cost of revenue 17.43K0
Gross profit 168.99%51.29K19.07K
Operating expense 364.35%1.79M-59.14%511.56K-26.69%627.74K-30.12%2.92M-36.52%887.09K-64.45%385.25K25.15%1.25M9.10%856.33K-31.36%4.17M-20.68%1.4M
Selling and administrative expenses 166.21%193.53K-61.60%93.5K-46.78%138.84K-55.10%561.05K6.01%348.99K-199.01%-292.3K-46.27%243.5K51.62%260.86K-41.81%1.25M-41.51%329.19K
Research and development costs 148.34%1.55M-60.55%377.51K-17.62%448.17K-19.26%2.15M-51.49%486.48K-13.43%626.07K98.65%956.85K-0.64%543.99K-24.31%2.66M-8.07%1M
Depreciation amortization depletion -21.08%40.63K-21.24%40.55K-20.86%40.74K-21.21%206.06K-21.04%51.62K-21.26%51.48K-21.26%51.48K-21.27%51.48K-37.04%261.53K-39.46%65.38K
-Depreciation and amortization -21.08%40.63K-21.24%40.55K-20.86%40.74K-21.21%206.06K-21.04%51.62K-21.26%51.48K-21.26%51.48K-21.27%51.48K-37.04%261.53K-39.46%65.38K
Operating profit -374.52%-1.74M97.50%-31.36K61.00%-301.4K31.69%-2.85M67.11%-459.58K66.21%-366.18K-38.04%-1.25M1.53%-772.92K10.80%-4.17M4.44%-1.4M
Net non-operating interest income (expenses) -26.13%-66.89K29.37%-51.89K49.52%-50.76K46.91%-291.62K64.49%-64.56K75.04%-53.03K7.52%-73.47K-33.02%-100.56K43.35%-549.3K-120.87%-181.81K
Non-operating interest income --0------------------0----------------
Non-operating interest expense 26.13%66.89K-29.37%51.89K-49.52%50.76K-46.91%291.62K-64.49%64.56K-75.04%53.03K-7.52%73.47K33.02%100.56K-43.35%549.3K120.87%181.81K
Other net income (expenses) -128.39%-34.97K-93.99%29.12K52.26%-3.58K147.50%255.07K29.68%-345.25K285.31%123.17K3,587.64%484.64K88.30%-7.49K-123.45%-536.97K-1,002.27%-490.99K
Gain on sale of security -128.39%-34.97K289.63%29.12K52.26%-3.58K1,037.61%210.63K369.08%110.31K285.31%123.17K-10.51%-15.36K88.30%-7.49K86.67%-22.47K198.46%23.52K
Special income (charges) --0--0----108.64%44.44K11.46%-455.57K--0--500K-----1,136.69%-514.5K-2,390.45%-514.5K
-Less:Impairment of capital assets --------------0------------------514.5K----
-Gain on sale of property,plant,equipment --0--0------44.44K---455.57K--0--500K------0--0
Income before tax -521.36%-1.84M93.56%-54.12K59.62%-355.74K45.11%-2.89M58.01%-869.39K76.58%-296.04K15.95%-840.65K4.72%-880.97K-56.62%-5.26M-30.27%-2.07M
Income tax 104.67%5.34K-447.78%-114.19K
Earnings from equity interest net of tax
Net income -521.36%-1.84M93.56%-54.12K59.62%-355.74K43.78%-2.89M55.28%-874.73K76.58%-296.04K15.95%-840.65K4.72%-880.97K-51.73%-5.15M-20.59%-1.96M
Net income continuous operations -521.36%-1.84M93.56%-54.12K59.62%-355.74K43.78%-2.89M55.28%-874.73K76.58%-296.04K15.95%-840.65K4.72%-880.97K-51.73%-5.15M-20.59%-1.96M
Noncontrolling interests
Net income attributable to the company -538.16%-1.89M93.56%-54.12K59.62%-355.74K43.78%-2.89M55.28%-874.73K76.58%-296.04K15.95%-840.65K4.72%-880.97K-51.73%-5.15M-20.59%-1.96M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders -538.16%-1.89M93.56%-54.12K59.62%-355.74K43.78%-2.89M55.28%-874.73K76.58%-296.04K15.95%-840.65K4.72%-880.97K-51.73%-5.15M-20.59%-1.96M
Diluted earnings per share -500.00%-0.0693.33%-0.00266.67%-0.0147.06%-0.0966.67%-0.0275.00%-0.0125.00%-0.0325.00%-0.03-21.43%-0.170.00%-0.06
Basic earnings per share -500.00%-0.0693.33%-0.00266.67%-0.0147.06%-0.0966.67%-0.0275.00%-0.0125.00%-0.0325.00%-0.03-21.43%-0.170.00%-0.06
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg

No Data